Prior authorization for biologic disease-modifying antirheumatic drugs: a description of US Medicaid programs.

Citation:
Fischer MA, Polinski JM, Servi AD, et al. Prior authorization for biologic disease-modifying antirheumatic drugs: a description of US Medicaid programs. Arthritis Rheum 2008 Nov 15;59(11):1611-7.
Principal Investigator: 
Document Type: 
Research Method: